CELLULAR MICROBIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1088495, encodeId=34061088495ed, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088496, encodeId=4cae1088496aa, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564900, encodeId=956f56490074, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=062878594, createdName=xibeiha, createdTime=Wed Dec 26 18:58:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562140, encodeId=4750562140b4, content=请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表: 发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1412273574, createdName=121ade3fm51暂无昵称, createdTime=Thu Oct 18 00:00:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551611, encodeId=8c6d551611bd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：17-Oct-2017 submitted Major Revision (19-Nov-2017) Minor Revision (10-Jan-2018) Accept (17-Jan-2018), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=943a2017839, createdName=靓仔, createdTime=Thu Jan 18 14:46:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551309, encodeId=4e2e55130967, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Jan 13 23:01:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543978, encodeId=7f505439e82a, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835233, encodeId=c67183523345, content=accept (09-jan-2017) minor revision (28-dec-2016) major revision (10-oct-2016) 19-sep-2016 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856f5414043, createdName=ms7093939182436036, createdTime=Tue Jan 10 10:34:44 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531664, encodeId=3c3a53166444, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Accept (09-Jan-2017) Minor Revision (28-Dec-2016) Major Revision (10-Oct-2016) 19-Sep-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Jan 10 10:30:00 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530541, encodeId=b0465305411c, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision . 01-Dec-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Dec 13 16:09:00 CST 2016, time=2016-12-13, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

Graphicalabstract是什么？

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088495, encodeId=34061088495ed, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088496, encodeId=4cae1088496aa, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564900, encodeId=956f56490074, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=062878594, createdName=xibeiha, createdTime=Wed Dec 26 18:58:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562140, encodeId=4750562140b4, content=请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表: 发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1412273574, createdName=121ade3fm51暂无昵称, createdTime=Thu Oct 18 00:00:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551611, encodeId=8c6d551611bd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：17-Oct-2017 submitted Major Revision (19-Nov-2017) Minor Revision (10-Jan-2018) Accept (17-Jan-2018), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=943a2017839, createdName=靓仔, createdTime=Thu Jan 18 14:46:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551309, encodeId=4e2e55130967, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Jan 13 23:01:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543978, encodeId=7f505439e82a, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835233, encodeId=c67183523345, content=accept (09-jan-2017) minor revision (28-dec-2016) major revision (10-oct-2016) 19-sep-2016 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856f5414043, createdName=ms7093939182436036, createdTime=Tue Jan 10 10:34:44 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531664, encodeId=3c3a53166444, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Accept (09-Jan-2017) Minor Revision (28-Dec-2016) Major Revision (10-Oct-2016) 19-Sep-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Jan 10 10:30:00 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530541, encodeId=b0465305411c, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision . 01-Dec-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Dec 13 16:09:00 CST 2016, time=2016-12-13, status=1, ipAttribution=)]

2021-12-28 Mia

投稿中一定要有Graphicalabstract么？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088495, encodeId=34061088495ed, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088496, encodeId=4cae1088496aa, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564900, encodeId=956f56490074, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=062878594, createdName=xibeiha, createdTime=Wed Dec 26 18:58:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562140, encodeId=4750562140b4, content=请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表: 发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1412273574, createdName=121ade3fm51暂无昵称, createdTime=Thu Oct 18 00:00:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551611, encodeId=8c6d551611bd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：17-Oct-2017 submitted Major Revision (19-Nov-2017) Minor Revision (10-Jan-2018) Accept (17-Jan-2018), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=943a2017839, createdName=靓仔, createdTime=Thu Jan 18 14:46:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551309, encodeId=4e2e55130967, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Jan 13 23:01:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543978, encodeId=7f505439e82a, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835233, encodeId=c67183523345, content=accept (09-jan-2017) minor revision (28-dec-2016) major revision (10-oct-2016) 19-sep-2016 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856f5414043, createdName=ms7093939182436036, createdTime=Tue Jan 10 10:34:44 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531664, encodeId=3c3a53166444, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Accept (09-Jan-2017) Minor Revision (28-Dec-2016) Major Revision (10-Oct-2016) 19-Sep-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Jan 10 10:30:00 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530541, encodeId=b0465305411c, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision . 01-Dec-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Dec 13 16:09:00 CST 2016, time=2016-12-13, status=1, ipAttribution=)]

2018-12-26 xibeiha

审稿速度:1.0 | 投稿命中率:25.0
经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。

186 0

[GetPortalCommentsPageByObjectIdResponse(id=1088495, encodeId=34061088495ed, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088496, encodeId=4cae1088496aa, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564900, encodeId=956f56490074, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=062878594, createdName=xibeiha, createdTime=Wed Dec 26 18:58:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562140, encodeId=4750562140b4, content=请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表: 发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1412273574, createdName=121ade3fm51暂无昵称, createdTime=Thu Oct 18 00:00:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551611, encodeId=8c6d551611bd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：17-Oct-2017 submitted Major Revision (19-Nov-2017) Minor Revision (10-Jan-2018) Accept (17-Jan-2018), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=943a2017839, createdName=靓仔, createdTime=Thu Jan 18 14:46:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551309, encodeId=4e2e55130967, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Jan 13 23:01:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543978, encodeId=7f505439e82a, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835233, encodeId=c67183523345, content=accept (09-jan-2017) minor revision (28-dec-2016) major revision (10-oct-2016) 19-sep-2016 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856f5414043, createdName=ms7093939182436036, createdTime=Tue Jan 10 10:34:44 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531664, encodeId=3c3a53166444, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Accept (09-Jan-2017) Minor Revision (28-Dec-2016) Major Revision (10-Oct-2016) 19-Sep-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Jan 10 10:30:00 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530541, encodeId=b0465305411c, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision . 01-Dec-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Dec 13 16:09:00 CST 2016, time=2016-12-13, status=1, ipAttribution=)]

2018-10-18 121ade3fm51暂无昵称

请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表::
研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表:
发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。

Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。

243 0

[GetPortalCommentsPageByObjectIdResponse(id=1088495, encodeId=34061088495ed, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088496, encodeId=4cae1088496aa, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564900, encodeId=956f56490074, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=062878594, createdName=xibeiha, createdTime=Wed Dec 26 18:58:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562140, encodeId=4750562140b4, content=请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表: 发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1412273574, createdName=121ade3fm51暂无昵称, createdTime=Thu Oct 18 00:00:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551611, encodeId=8c6d551611bd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：17-Oct-2017 submitted Major Revision (19-Nov-2017) Minor Revision (10-Jan-2018) Accept (17-Jan-2018), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=943a2017839, createdName=靓仔, createdTime=Thu Jan 18 14:46:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551309, encodeId=4e2e55130967, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Jan 13 23:01:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543978, encodeId=7f505439e82a, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835233, encodeId=c67183523345, content=accept (09-jan-2017) minor revision (28-dec-2016) major revision (10-oct-2016) 19-sep-2016 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856f5414043, createdName=ms7093939182436036, createdTime=Tue Jan 10 10:34:44 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531664, encodeId=3c3a53166444, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Accept (09-Jan-2017) Minor Revision (28-Dec-2016) Major Revision (10-Oct-2016) 19-Sep-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Jan 10 10:30:00 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530541, encodeId=b0465305411c, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision . 01-Dec-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Dec 13 16:09:00 CST 2016, time=2016-12-13, status=1, ipAttribution=)]

2018-01-18 靓仔

审稿速度:3.0 | 投稿命中率:25.0
经验分享：17-Oct-2017 submitted
Major Revision (19-Nov-2017)
Minor Revision (10-Jan-2018)
Accept (17-Jan-2018)

291 0

[GetPortalCommentsPageByObjectIdResponse(id=1088495, encodeId=34061088495ed, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088496, encodeId=4cae1088496aa, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564900, encodeId=956f56490074, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=062878594, createdName=xibeiha, createdTime=Wed Dec 26 18:58:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562140, encodeId=4750562140b4, content=请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表: 发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1412273574, createdName=121ade3fm51暂无昵称, createdTime=Thu Oct 18 00:00:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551611, encodeId=8c6d551611bd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：17-Oct-2017 submitted Major Revision (19-Nov-2017) Minor Revision (10-Jan-2018) Accept (17-Jan-2018), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=943a2017839, createdName=靓仔, createdTime=Thu Jan 18 14:46:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551309, encodeId=4e2e55130967, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Jan 13 23:01:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543978, encodeId=7f505439e82a, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835233, encodeId=c67183523345, content=accept (09-jan-2017) minor revision (28-dec-2016) major revision (10-oct-2016) 19-sep-2016 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856f5414043, createdName=ms7093939182436036, createdTime=Tue Jan 10 10:34:44 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531664, encodeId=3c3a53166444, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Accept (09-Jan-2017) Minor Revision (28-Dec-2016) Major Revision (10-Oct-2016) 19-Sep-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Jan 10 10:30:00 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530541, encodeId=b0465305411c, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision . 01-Dec-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Dec 13 16:09:00 CST 2016, time=2016-12-13, status=1, ipAttribution=)]

2018-01-13 Fan of Vibrio

审稿速度:1.0 | 投稿命中率:5.0
经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。

304 0

[GetPortalCommentsPageByObjectIdResponse(id=1088495, encodeId=34061088495ed, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088496, encodeId=4cae1088496aa, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564900, encodeId=956f56490074, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=062878594, createdName=xibeiha, createdTime=Wed Dec 26 18:58:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562140, encodeId=4750562140b4, content=请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表: 发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1412273574, createdName=121ade3fm51暂无昵称, createdTime=Thu Oct 18 00:00:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551611, encodeId=8c6d551611bd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：17-Oct-2017 submitted Major Revision (19-Nov-2017) Minor Revision (10-Jan-2018) Accept (17-Jan-2018), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=943a2017839, createdName=靓仔, createdTime=Thu Jan 18 14:46:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551309, encodeId=4e2e55130967, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Jan 13 23:01:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543978, encodeId=7f505439e82a, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835233, encodeId=c67183523345, content=accept (09-jan-2017) minor revision (28-dec-2016) major revision (10-oct-2016) 19-sep-2016 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856f5414043, createdName=ms7093939182436036, createdTime=Tue Jan 10 10:34:44 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531664, encodeId=3c3a53166444, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Accept (09-Jan-2017) Minor Revision (28-Dec-2016) Major Revision (10-Oct-2016) 19-Sep-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Jan 10 10:30:00 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530541, encodeId=b0465305411c, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision . 01-Dec-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Dec 13 16:09:00 CST 2016, time=2016-12-13, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

317 0

[GetPortalCommentsPageByObjectIdResponse(id=1088495, encodeId=34061088495ed, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088496, encodeId=4cae1088496aa, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564900, encodeId=956f56490074, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=062878594, createdName=xibeiha, createdTime=Wed Dec 26 18:58:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562140, encodeId=4750562140b4, content=请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表: 发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1412273574, createdName=121ade3fm51暂无昵称, createdTime=Thu Oct 18 00:00:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551611, encodeId=8c6d551611bd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：17-Oct-2017 submitted Major Revision (19-Nov-2017) Minor Revision (10-Jan-2018) Accept (17-Jan-2018), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=943a2017839, createdName=靓仔, createdTime=Thu Jan 18 14:46:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551309, encodeId=4e2e55130967, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Jan 13 23:01:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543978, encodeId=7f505439e82a, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835233, encodeId=c67183523345, content=accept (09-jan-2017) minor revision (28-dec-2016) major revision (10-oct-2016) 19-sep-2016 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856f5414043, createdName=ms7093939182436036, createdTime=Tue Jan 10 10:34:44 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531664, encodeId=3c3a53166444, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Accept (09-Jan-2017) Minor Revision (28-Dec-2016) Major Revision (10-Oct-2016) 19-Sep-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Jan 10 10:30:00 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530541, encodeId=b0465305411c, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision . 01-Dec-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Dec 13 16:09:00 CST 2016, time=2016-12-13, status=1, ipAttribution=)]

2017-01-10 ms7093939182436036

accept (09-jan-2017)
minor revision (28-dec-2016)
major revision (10-oct-2016)
19-sep-2016 submitted

109 0

[GetPortalCommentsPageByObjectIdResponse(id=1088495, encodeId=34061088495ed, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088496, encodeId=4cae1088496aa, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564900, encodeId=956f56490074, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=062878594, createdName=xibeiha, createdTime=Wed Dec 26 18:58:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562140, encodeId=4750562140b4, content=请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表: 发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1412273574, createdName=121ade3fm51暂无昵称, createdTime=Thu Oct 18 00:00:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551611, encodeId=8c6d551611bd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：17-Oct-2017 submitted Major Revision (19-Nov-2017) Minor Revision (10-Jan-2018) Accept (17-Jan-2018), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=943a2017839, createdName=靓仔, createdTime=Thu Jan 18 14:46:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551309, encodeId=4e2e55130967, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Jan 13 23:01:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543978, encodeId=7f505439e82a, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835233, encodeId=c67183523345, content=accept (09-jan-2017) minor revision (28-dec-2016) major revision (10-oct-2016) 19-sep-2016 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856f5414043, createdName=ms7093939182436036, createdTime=Tue Jan 10 10:34:44 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531664, encodeId=3c3a53166444, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Accept (09-Jan-2017) Minor Revision (28-Dec-2016) Major Revision (10-Oct-2016) 19-Sep-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Jan 10 10:30:00 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530541, encodeId=b0465305411c, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision . 01-Dec-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Dec 13 16:09:00 CST 2016, time=2016-12-13, status=1, ipAttribution=)]

2017-01-10 crystalw

审稿速度:3.0 | 投稿命中率:25.0
经验分享：Accept (09-Jan-2017)
Minor Revision (28-Dec-2016)
Major Revision (10-Oct-2016)
19-Sep-2016 submitted

329 0

[GetPortalCommentsPageByObjectIdResponse(id=1088495, encodeId=34061088495ed, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088496, encodeId=4cae1088496aa, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564900, encodeId=956f56490074, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：还挺稳的杂志，如果能冲5就好了。关键是没有版面费，审稿速度也很快。从投稿到接受就2个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=062878594, createdName=xibeiha, createdTime=Wed Dec 26 18:58:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562140, encodeId=4750562140b4, content=请问这个期刊要版面费吗？谢谢Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。Fan of Vibrio 2018-01-13 23:01:00 发表: 发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=Fan of Vibrio 2018-01-13 发表:: 研究方向：细胞信号途径;病原菌或病毒与细胞的相互作用; 接收率：约5% 审稿时间：约1个月发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1412273574, createdName=121ade3fm51暂无昵称, createdTime=Thu Oct 18 00:00:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551611, encodeId=8c6d551611bd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：17-Oct-2017 submitted Major Revision (19-Nov-2017) Minor Revision (10-Jan-2018) Accept (17-Jan-2018), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=943a2017839, createdName=靓仔, createdTime=Thu Jan 18 14:46:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551309, encodeId=4e2e55130967, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发表文章中大约只有8%为我国作者发表的文章，关注病原菌或病毒感染细胞后影响细胞的信号途径，而且实验要细致、分子机制要新颖，比Infection and Immunity和Mol Micro都难中。不做或做得很肤浅细胞通路的没希望在该杂志上发表文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Jan 13 23:01:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543978, encodeId=7f505439e82a, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835233, encodeId=c67183523345, content=accept (09-jan-2017) minor revision (28-dec-2016) major revision (10-oct-2016) 19-sep-2016 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856f5414043, createdName=ms7093939182436036, createdTime=Tue Jan 10 10:34:44 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531664, encodeId=3c3a53166444, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Accept (09-Jan-2017) Minor Revision (28-Dec-2016) Major Revision (10-Oct-2016) 19-Sep-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Jan 10 10:30:00 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530541, encodeId=b0465305411c, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision . 01-Dec-2016 submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d6d1624684, createdName=crystalw, createdTime=Tue Dec 13 16:09:00 CST 2016, time=2016-12-13, status=1, ipAttribution=)]

2016-12-13 crystalw

审稿速度:1.0 | 投稿命中率:25.0
经验分享：19-Sep-2016 submitted, 10-Oct-2016 Major Revision .
01-Dec-2016 submitted

419 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务